13F

Stock

Adaptimmune Therapeutics Plc

ADAPY · held by 2 managers

Reported value

$47.6K

Holders

2

+1 new · −0 exited

Holders’ est. mark

−$1.23K

Price effect on 1 books still in the name

Largest holder

$47.6K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC50.1K$47.6K−$1.23KCut−$1.23K
DANSKE BANK A/S1$1New

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.